Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
12.28 USD | +1.40% |
|
+31.94% | +411.25% |
Jul. 09 | Emergent Biosolutions, Johnson & Johnson Settle Dispute Over COVID-19 Vaccine Manufacturing | MT |
Jul. 08 | Emergent, J&J settle COVID vaccine supply deal dispute | RE |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
Subscribe![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+411.25% | 635M | |
+57.18% | 848B | |
+31.64% | 627B | |
-0.57% | 363B | |
+15.28% | 318B | |
+12.33% | 299B | |
+15.51% | 243B | |
+16.72% | 225B | |
+16.06% | 179B | |
+3.28% | 167B |
- Stock Market
- Equities
- EBS Stock
- News Emergent BioSolutions Inc.
- Transcript : Emergent BioSolutions Inc. Presents at JPMorgan 40th Annual Healthcare Conference, Jan-10-2022 08